I now have comprehensive information from multiple authoritative sources. Let me compile the full answer.
Gastrointestinal Manifestations in Turner Syndrome
Turner syndrome (45,X or mosaic) occurs in ~1:2500 live female births and, beyond its classic features of short stature, gonadal dysgenesis, and congenital lymphedema, carries a well-recognized spectrum of GI involvement.
1. Intestinal Vascular Malformations - GI Bleeding
The most acutely dangerous GI complication. Patients develop telangiectasias and vascular malformations throughout the GI tract (most commonly the jejunum), which can cause:
- Recurrent occult GI bleeding / melena
- Overt hemorrhage - sometimes severe or transfusion-dependent
- A 2026 case report describes hemorrhagic jejunal vascular malformations with loop telangiectasia as a cause of significant bleeding [PMID: 41655792]
Goldman-Cecil Medicine notes Turner syndrome alongside scleroderma and CREST syndrome as causes of GI telangiectasias. - Goldman-Cecil Medicine, GI Ectasias section
2. Inflammatory Bowel Disease (IBD)
Turner syndrome carries a significantly increased incidence of IBD, particularly Crohn's disease. This association is genetically rooted - Turner syndrome is among a small group of chromosomal syndromes (also Down syndrome, chr22q11 deletion) linked to IBD susceptibility loci. Over 100 IBD susceptibility genes have been mapped, with developmental syndromes forming a recognized genetic risk category. - Thompson & Thompson Genetics and Genomics in Medicine, 9th ed.
Goldman-Cecil lists Turner syndrome alongside glycogen storage disease type Ib and Hermansky-Pudlak syndrome as specific associations with IBD. Women with Turner syndrome have an increased incidence of IBD as part of their broader autoimmune predisposition. - Goldman-Cecil Medicine
3. Celiac Disease
Turner syndrome is one of the established at-risk groups for celiac disease, alongside Down syndrome and various autoimmune disorders. Screening is warranted because:
- Prevalence is higher than in the general population
- Celiac disease may be silent or atypical in presentation
- The risk is related to the autoimmune background of Turner syndrome
Both Harrison's and Yamada's explicitly name Turner syndrome as a celiac disease risk group. The Harriet Lane Handbook lists Turner syndrome among conditions requiring celiac screening (along with IgA deficiency and autoimmune disorders). - Harrison's Principles of Internal Medicine, 22e; Yamada's Textbook of Gastroenterology, 7th ed.; Harriet Lane Handbook, 23rd ed.
4. Liver Abnormalities
This is the most heterogeneous category:
| Liver Finding | Notes |
|---|
| Elevated alkaline phosphatase | Mild cholestasis; not related to exogenous estrogen use |
| Nonalcoholic fatty liver disease (NAFLD) | Linked to insulin resistance, obesity, and metabolic syndrome - a subset of women with Turner syndrome have fully developed metabolic syndrome |
| Porto-sinusoidal vascular disorder (PSVD) | An under-recognized vascular liver lesion; a 2025 case series reports 3 adult women with TS and persistent liver enzyme elevation due to PSVD - may occur even without cardiometabolic risk factors [PMID: 40507741] |
| Nodular regenerative hyperplasia | Reported in the literature as a hepatic complication |
| Direct hyperbilirubinemia / cholestasis | Turner syndrome is listed as a chromosomal cause of direct hyperbilirubinemia in the Harriet Lane Handbook |
Key point: liver enzyme elevation in Turner syndrome requires careful workup - causes range from metabolic (NAFLD, insulin resistance) to vascular (PSVD, nodular regenerative hyperplasia) to autoimmune (autoimmune hepatitis), and distinguishing them has implications for management. - Yamada's Textbook of Gastroenterology, 7th ed.; Robbins Pathologic Basis of Disease
5. Eating Disorders / Nutritional Issues
Turner syndrome is associated with a greater risk for anorexia nervosa. This contributes to nutritional deficiencies and may complicate management of other GI conditions. - Yamada's Textbook of Gastroenterology, 7th ed.
Summary Table
| Manifestation | Key Features |
|---|
| GI vascular malformations / telangiectasias | Recurrent hemorrhage, especially jejunal; can be transfusion-dependent |
| Inflammatory bowel disease | Crohn's > UC; genetically linked; part of autoimmune predisposition |
| Celiac disease | Increased prevalence; screen with IgA anti-tTG |
| Liver: alkaline phosphatase elevation / cholestasis | Mild; not estrogen-related |
| Liver: NAFLD / metabolic liver disease | Linked to insulin resistance, obesity, growth hormone therapy |
| Liver: PSVD / nodular regenerative hyperplasia | Vascular; may occur without classic risk factors |
| Anorexia nervosa | Increased risk; nutritional compromise |
Clinical Implications
- Routine liver function monitoring is recommended in Turner syndrome guidelines
- Celiac screening (IgA anti-tTG) should be performed periodically
- Unexplained GI bleeding should prompt evaluation for vascular malformations (capsule endoscopy, enteroscopy)
- Liver biopsy may be needed when enzyme elevation is persistent and the etiology is unclear (PSVD may be missed on non-invasive tests)
- The autoimmune backdrop (thyroid, celiac, IBD) suggests a shared immune dysregulation mechanism related to X-chromosome haploinsufficiency